Survival Benefit Conferred by Topical Antimicrobial Preparations in Burn Patients: A Historical Perspective

Journal of Trauma - Injury, Infection and Critical Care

Volumn 56, Issue 4, 2004, Pages 863-866

  Brown, Timothy P La H ^a,b   Cancio, Leopoldo C ^b   McManus, Albert T ^b   Mason Jr , Arthur D ^b  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Burns; Disaster planning; Mafenide; Military medicine; Survival rate; Wound infection

Indexed keywords

ANTIINFECTIVE AGENT; MAFENIDE ACETATE;

ADULT; AGE; ANTIBIOTIC THERAPY; ARMY; BODY SURFACE; BURN; DRUG FORMULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MILITARY MEDICINE; MORTALITY; PRIORITY JOURNAL; REVIEW; SOLDIER; SURVIVAL; UNITED STATES; WOUND INFECTION;

EID: 2042428748     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000044565.69410.95     Document Type: Review

References (22)

1. Sparkes BG. Treating mass burns in warfare, disaster or terrorist strikes. Burns. 1997;23:238-247.
2. Bowen TE, Bellamy RF. Emergency War Surgery: Second United States Revision of the Emergency War Surgery NATO Handbook. Washington, DC: US Government Printing Office; 1988.
3. Pruitt BA Jr, O'Neill JA Jr, Moncrief JA, Lindberg RB. Successful control of burn-wound sepsis. JAMA. 1968;203:1054-1056.
4. Lindberg RB, Moncrief JA, Mason AD Jr. Control of experimental and clinical burn wound sepsis by topical application of sulfamylon compounds. Ann NY Acad Sci. 1968;150:950-960.
5. Pruitt BA, Mason AD Jr. Epidemiological, demographic and outcome characteristics of burn injury. In: Herndon DN, ed. Total Burn Care. London: W.B. Saunders; 1996:5-15.
6. Goodwin CW, Yurt RW. Epidemiology of burn wounds. In: Davis JM, Shires GT, eds. Host Defenses in Trauma and Surgery. New York: Raven Press; 1986:5-18.
7. Liedberg NC, Reiss E, Artz CP. Infection in burns. III. Septicemia, a common cause of death. Surg Gynecol Obstet. 1954;99:151-158.
8. Artz CP, Teschan PE. Infection - A major unresolved problem in severe trauma. Am J Surg. 1957;93:647-53.
9. Tumbusch WT, Vogel EH, Butkiewicz JV, Graber CD, Larson DL, Mitchel ET. Septicemia in burn injury. J Trauma. 1961;1:22-31.
10. Rabin ER, Graber CD, Vogel EH, Finkelstein RA, Tumbusch WA. Fatal pseudomonas infection in burned patients. N Engl J Med. 1961;265:1225-1231.
11. MacMillan BG, Artz CP. A planned evaluation of early excision of more than twenty-five per cent of the body surface in burns. Surg Forum. 1956;7:88-93.
12. Switzer WE, Jones JW, Moncrief JA. Evaluation of early excision of burns in children. J Trauma. 1965;5:540-546.
13. Taylor PH, Moncrief JA, Pugsley LQ, Rose LR, Switzer WE. The management of extensively burned patients by staged excision. Surg Gynecol Obstet. 1962;115:347-352.
14. McManus AT, Mason AD Jr, McManus WF, Pruitt BA Jr. Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur J Clin Microbiol. 1985;4:219-223.
15. Scott R. Munich workshop on epidemiology, triage and treatment of military burn patients. Defense Research Group 11, Panel VIII, Annual Report: NATO AC/243 (Panel VIII/RSG. 11)D/3, 1985.
16. Crocq L, Doucet J. Physiopathology of serious burn cases. Defence Research Group 9, Panel VIII: NATO AC/243 (Panel VIII/RSG.9)D/26, 1979.
17. Pruitt BA Jr. Centennial changes in surgical care and research. Ann Surg. 2000;232:287-301.
18. Pruitt BA Jr, Goodwin CW, Cioffi WG. Thermal injuries. In: Davis JH, Sheldon GF, eds. Surgery: A Problem-Solving Approach. St. Louis: Mosby; 1995:643-720.
19. White MG, Asch MJ. Acid-base effects of topical mafenide acetate in the burned patient. N Engl J Med. 1971;284:1281-1286.
20. Harrison HN, Bales H, Jacoby F. The behavior of mafenide acetate as a basis for its clinical use. Arch Surg. 1971;103:449-453.
21. Teplitz C, Davis D, Mason AD Jr, Moncrief JA. Pseudomonas burn wound sepsis. I. Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res. 1964;4:200-216.
22. Teplitz C, Davis D, Walker HL, Raulston GL, Mason AD Jr, Moncrief JA. Pseudomonas burn wound sepsis: II. Hematogenous infection at the junction of the burn wound and the unburned hypodermis. J Surg Res. 1964;4:217-222.